Summary
The pharmacokinetic characteristics of the analgesic phenacetin have been determined in six healthy adults. After rapid i.v. injection of 250 mg phenacetin, the log plasma concentrations versus time curves were evaluated according to the rules of a two-compartment open model. The elimination half-life (t 1/2) β varied from 37 to 74 minutes. The volume of distribution (Vd) β ranged from 1.0 to 2.1 1 per kg body weight. The total clearance of the drug was high and approximated the average value of hepatic blood flow in normal adults. In agreement with this finding, the bioavailability of a small oral dose of phenacetin (0.25 g) was almost nil, as the bulk of the drug was cleared during its first pass through the liver. With large oral doses (1.0 g) the first-pass effect decreased and availability increased. The results are discussed and related to current general views of the liver-first-pass phenomenon.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barr, W.H.: Factors involved in the assessment of systemic or biologic availability of drug products. Drug Inform. Bull.3 27 (1969)
Boyes, R.N., Adams, H.J., Duce, B.R.: Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs. J. Pharmacol. exp. Ther.174 1–8 (1970)
Bradley, S.E.: The hepatic circulation.In: Handbook of physiology, Sect. 2, Vol. II, p. 1387. Baltimore, Md: William & Wilkins Comp. 1963
Brodie, B.B., Axelrod, J.: The estimation of acetanilide and its metabolic products in biological fluids and tissues. J. Pharmacol. exp. Ther.94 22–28 (1948)
Brodie, B.B., Axelrod, J.: The fate of acetophenetidin in man. J. Pharmacol. exp. Ther.97 58–67 (1949)
Dubach, U.C., Raaflaub, J.: Neue Aspekte zur Frage der Nephrotoxizität von Phenacetin. Experientia25 956–958 (1969)
Gibaldi, M., Feldman, S.: Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve. J. pharm. Sci.58 1477–1480 (1969)
Gibaldi, M., Boyes, R.N., Feldman, S.: Influence of first-pass effect on availability of drugs on oral administration. J. pharm. Sci.60 1338–1340 (1971)
Harris, P.A., Riegelman, S.: Influence of the route of administration on the area under the plasma concentration-time curve. J. pharm. Sci.58 71–75 (1969)
Kampffmeyer, H.G.: Elimination of phenacetin and phenazone by man before and after treatment with phenobarbital. Europ. J. clin. Pharmacol.3 113–118 (1971)
Pantuck, E.J., Kuntzman, R., Conney, A.H.: Decreased concentration of phenacetin in plasma of cigarette smokers. Science175 1248–1250 (1972)
Prescott, L.F., Sansur, M., Levin, W., Conney, A.H.: The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man. Clin. Pharmacol. Ther.9 605–614 (1968)
Raaflaub, J., Dubach, U.C.: Dose-dependent change in the pattern of phenacetin metabolism in man. Klin. Wschr.47 1286–1287 (1969)
Raaflaub, J., Dubach, U.C.: Zur Frage der Pathogenese der chronisch-interstitiellen Nephritis nach protrahiertem Schmerzmittelabusus. Klin. Wschr.55 489–497 (1972)
Raaflaub, J., Dubach, U.C.: Unpublished data
Rowland, M.: Influence of route of administration on drug availability. J. pharm. Sci.61 70–74 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raaflaub, J., Dubach, U.C. On the pharmacokinetics of phenacetin in man. Eur J Clin Pharmacol 8, 261–265 (1975). https://doi.org/10.1007/BF00567125
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00567125